Market Tracker

12/08 3:07pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.17
Delayed Data
As of 2:48pm ET
 -0.07 / -5.65%
Today’s Change
1.10
Today|||52-Week Range
15.50
-88.18%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.24
Today’s open1.24
Day’s range1.15 - 1.24
Volume89,962
Average volume (3 months)90,236
Market cap$9.6M
Dividend yield--
Data as of 2:48pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+30.45%
Earnings growth (this year)+61.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.74%
P/E ratioNM
Price/Sales10.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...-0.04-2.90%
PULMPulmatrix Inc+0.06+8.96%
JAGXJaguar Animal Health...-0.04-5.32%
BSPMBiostar Pharmaceutic...-0.06-1.87%
Data as of 2:52pm ET, 12/08/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.0M
Net profit margin-393.12%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts